These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1857411)

  • 21. N-methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing, and its effect on fowl plague virus maturation.
    Romero PA; Datema R; Schwarz RT
    Virology; 1983 Oct; 130(1):238-42. PubMed ID: 6636538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing.
    Dedera D; Vander Heyden N; Ratner L
    AIDS Res Hum Retroviruses; 1990 Jun; 6(6):785-94. PubMed ID: 2364019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.
    Pal R; DeVico A; Rittenhouse S; Sarngadharan MG
    Virology; 1993 Jun; 194(2):833-7. PubMed ID: 8503188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A heparin which binds to the envelope glycoprotein gp120 inhibits human immunodeficiency virus replication.
    Cardin AD; Taylor DL; Krstenansky JL; Tyms AS; Jackson RL
    Trans Assoc Am Physicians; 1989; 102():101-9. PubMed ID: 2561637
    [No Abstract]   [Full Text] [Related]  

  • 26. Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp.
    Matsuzaki K; Ikeda H; Ogino T; Matsumoto A; Woodruff HB; Tanaka H; Omura S
    J Antibiot (Tokyo); 1994 Oct; 47(10):1173-4. PubMed ID: 7961171
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 28. The interaction of CD4 with HIV-1 gp120.
    Silberman SL; Goldman SJ; Mitchell DB; Tong AT; Rosenstein Y; Diamond DC; Finberg RW; Schreiber SL; Burakoff SJ
    Semin Immunol; 1991 May; 3(3):187-92. PubMed ID: 1888898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Several new AIDS drugs being tested.
    Oncology (Williston Park); 1989 Jun; 3(6):114, 120. PubMed ID: 2561901
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycin.
    Platt FM; Karlsson GB; Jacob GS
    Eur J Biochem; 1992 Aug; 208(1):187-93. PubMed ID: 1387360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
    Parish CR; Low L; Warren HS; Cunningham AL
    J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of biologically active derivatives of D-glucosamine-4-phosphate and 1-thyminyl-D-glucosamine-4,6-disulfate.
    Idegami K; Ikeda K; Achiwa K
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1766-8. PubMed ID: 2208395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4 antagonists.
    McKeating JA
    Biochem Soc Trans; 1992 May; 20(2):521-5. PubMed ID: 1397653
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycoscience moves from the laboratory to the clinic.
    Rowe PM
    Lancet; 1999 Jul; 354(9176):402. PubMed ID: 10437881
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of 1-deoxynojirimycin and 1-deoxymannojirimycin.
    Setoi H; Takeno H; Hashimoto M
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2642-5. PubMed ID: 2945651
    [No Abstract]   [Full Text] [Related]  

  • 39. 4th International Workshop on HIV Drug Resistance. Sardinia, Italy, July 6-9, 1995. Abstracts.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 3():S1-46. PubMed ID: 8605585
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is it possible to treat the brain? Recent advances in inherited neurodegenerative disorders].
    Eto Y
    No To Hattatsu; 2007 Mar; 39(2):87-92. PubMed ID: 17370626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.